{"public_id":"cl_7afc3fb76662179c4fd64b5b531c4117","status":"active","superseded_by_public_id":null,"corpus_id":12969764,"text":"Blood endotoxin activity did not change significantly over time and did not differ between the lubiprostone and untreated groups at any measured time point.","confidence":0.95,"paper":{"corpus_id":12969764,"title":"Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers","url":"https://sah.borca.ai/papers/12969764"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_1b1e90e6687a55dd72e84ebff2199ef8","name":"untreated group","description":"The comparison group that did not receive lubiprostone.","types":["comparison group"],"url":"https://sah.borca.ai/concepts/co_1b1e90e6687a55dd72e84ebff2199ef8"},{"public_id":"co_1fedd280e625d50904dff99c4608fec9","name":"lubiprostone","description":"A drug used here at 24 μg/day to test whether it can improve intestinal barrier function.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_1fedd280e625d50904dff99c4608fec9"},{"public_id":"co_76265f0d28f7cc8fd19706c42e373af9","name":"blood endotoxin activity","description":"A blood-based measure of endotoxin-related activity assessed alongside permeability.","types":["biomarker"],"url":"https://sah.borca.ai/concepts/co_76265f0d28f7cc8fd19706c42e373af9"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_7afc3fb76662179c4fd64b5b531c4117"}